Harwood Feffer LLP Announces Investigation of Sequenom Inc.

NEW YORK, Sept. 10, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Sequenom Inc. ("Sequenom" or the "Company") (NASDAQ: SQNM) concerning whether the board has breached its fiduciary duties to shareholders.

(Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On July 24, 2013, the Company disclosed its financial results for the third quarter of 2013.  Although it reported a 91% increase in total revenues for the quarter, it also reported a net loss of $31 million, compared to a net loss for the same period during the previous year of $29.6 million.  According to the Company, it suffered from delays in collecting payments as a result of certain medical coding changes.  However, many of these entities had yet to implement the new codes.       

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Sequenom shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Matthew M. Houston, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400 
                         (212) 935-7400
Email:  bsachsmichaels@hfesq.com 
Website:   http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2013 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP